Chlorthalidone Elicits Favorable Initial Reduction in SBP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
Hypertension 2017 Jul 01;70(1)94-102, SS Dhruva, C Huang, ES Spatz, AC Coppi, F Warner, SX Li, H Lin, X Xu, CD Furberg, BR Davis, SL Pressel, RR Coifman, HM KrumholzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.